Your session is about to expire
← Back to Search
Chronotherapy for Sleep Disorders After Acute Coronary Syndrome
Study Summary
This trial will test a "combined chronotherapy" intervention consisting of morning bright light therapy and evening blue light blocking, administered daily for 4 weeks in patients who experienced acute coronary syndrome. The primary aims are study feasibility, acceptability, appropriateness, and usability.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have eye diseases like glaucoma or retinopathy.I do not have reliable access to a phone or email.I can communicate effectively in English or Spanish.I am currently taking medication for depression or anxiety.I am taking medications that make my skin more sensitive to light.I am 18 years old or older.You are unable to see.I do not speak Spanish.You work at night.I often have trouble sleeping or sleep less than 6 hours most nights.The healthcare provider and the patient have confirmed acute coronary syndrome (ACS).The healthcare provider and patient have confirmed acute coronary syndrome (ACS).I often have trouble sleeping or sleep less than 6 hours most nights.I had a heart problem within the last 3 months.I often get less than 6 hours of sleep or have insomnia.You have a history of bipolar disorder or have shown signs of bipolar disorder in a questionnaire.I am able to follow the study's requirements without any issues.I had a heart problem within the last 3 months.Both the doctor and the patient have confirmed acute coronary syndrome (ACS).You can participate in PHASE A of the trial if you meet the following requirements.I often have trouble sleeping or sleep less than 6 hours most nights.I had a heart problem within the last 3 months.I had a heart attack or related event in the last 3 months.I do not speak English.I am 18 years old or older.Both the healthcare provider and the patient have confirmed acute coronary syndrome (ACS).
- Group 1: Phase B - active CC treatment
- Group 2: Phase A - open label single-arm
- Group 3: Phase B - sleep hygiene education control group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current sample size of this research project?
"Affirmative, the data hosted on clinicaltrials.gov attests to this medical study's current requirement for 20 participants from 1 centre. The trial was initially posted April 18th 2022 and recently updated May 4th 2022."
Are new participants being recruited for this trial at present?
"Affirmative. According to clinicaltrials.gov, patient recruitment for this medical trial is currently underway; it was first posted on April 18th 2022 and was most recently modified on May 4th 2022. The study requires 20 participants from a single clinic."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger